Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 63

1.

Corrigendum to 'An evaluation of hepatic enzyme elevations among HIV-infected released prisoners enrolled in two randomized placebo-controlled trials of extended release naltrexone' [Journal of Substance Abuse Treatment 47 (2014) 35-40].

Vagenas P, Di Paola A, Herme M, Lincoln T, Skiest DJ, Altice FL, Springer SA.

J Subst Abuse Treat. 2017 Jun;77:44. doi: 10.1016/j.jsat.2017.03.008. Epub 2017 Mar 18. No abstract available.

2.

Investigation of Efavirenz Discontinuation in Multi-ethnic Populations of HIV-positive Individuals by Genetic Analysis.

Cummins NW, Neuhaus J, Chu H, Neaton J, Wyen C, Rockstroh JK, Skiest DJ, Boyd MA, Khoo S, Rotger M, Telenti A, Weinshilboum R, Badley AD; INSIGHT Study Group.

EBioMedicine. 2015 May 12;2(7):706-12. doi: 10.1016/j.ebiom.2015.05.012. eCollection 2015 Jul.

3.

Design and methods of a double blind randomized placebo-controlled trial of extended-release naltrexone for HIV-infected, opioid dependent prisoners and jail detainees who are transitioning to the community.

Di Paola A, Lincoln T, Skiest DJ, Desabrais M, Altice FL, Springer SA.

Contemp Clin Trials. 2014 Nov;39(2):256-68. doi: 10.1016/j.cct.2014.09.002. Epub 2014 Sep 18.

4.

Outcomes of influenza A(H1N1)pdm09 virus infection: results from two international cohort studies.

Lynfield R, Davey R, Dwyer DE, Losso MH, Wentworth D, Cozzi-Lepri A, Herman-Lamin K, Cholewinska G, David D, Kuetter S, Ternesgen Z, Uyeki TM, Lane HC, Lundgren J, Neaton JD; INSIGHT Influenza Study Group.

PLoS One. 2014 Jul 8;9(7):e101785. doi: 10.1371/journal.pone.0101785. eCollection 2014.

5.

An evaluation of hepatic enzyme elevations among HIV-infected released prisoners enrolled in two randomized placebo-controlled trials of extended release naltrexone.

Vagenas P, Di Paola A, Herme M, Lincoln T, Skiest DJ, Altice FL, Springer SA.

J Subst Abuse Treat. 2014 Jul;47(1):35-40. doi: 10.1016/j.jsat.2014.02.008. Epub 2014 Mar 12.

6.

Toxoplasma encephalitis in an HIV-infected patient on highly active antiretroviral therapy despite sustained immune response.

Atreya AR, Arora S, Gadiraju VT, Martagon-Villamil J, Skiest DJ.

Int J STD AIDS. 2014 Apr;25(5):383-6. doi: 10.1177/0956462413506891. Epub 2013 Oct 9.

PMID:
24108450
7.

Genome sequence of Listeria monocytogenes 07PF0776, a cardiotropic serovar 4b strain.

McMullen PD, Gillaspy AF, Gipson J, Bobo LD, Skiest DJ, Freitag NE.

J Bacteriol. 2012 Jul;194(13):3552. doi: 10.1128/JB.00616-12.

8.

Similar efficacy of raltegravir when used with or without a protease inhibitor in treatment-experienced patients.

Skiest DJ, Cohen C, Mounzer K, Haigney Z, Barker D, Gottlieb M, Bellman PC, Dejesus E, Khanlou H, Ruane PJ, Hsiao CB, Abriola K, Rashbaum B, Bellos N, Ward D, Colson A, Santiago F, Habel A, Garb J.

HIV Clin Trials. 2011 May-Jun;12(3):131-40. doi: 10.1310/hct1203-131.

PMID:
21684853
9.

Evidence for subpopulations of Listeria monocytogenes with enhanced invasion of cardiac cells.

Alonzo F 3rd, Bobo LD, Skiest DJ, Freitag NE.

J Med Microbiol. 2011 Apr;60(Pt 4):423-34. doi: 10.1099/jmm.0.027185-0. Epub 2011 Jan 25.

10.

Low prevalence of primary HIV resistance in western Massachusetts.

Iarikov DE, Irizarry-Acosta M, Martorell C, Hoffman RP, Skiest DJ.

J Int Assoc Physicians AIDS Care (Chic). 2010 Jul-Aug;9(4):227-31. doi: 10.1177/1545109710374998.

PMID:
20798402
11.

Comparative effectiveness of macrolides and quinolones for patients hospitalized with acute exacerbations of chronic obstructive pulmonary disease (AECOPD).

Rothberg MB, Pekow PS, Lahti M, Brody O, Skiest DJ, Lindenauer PK.

J Hosp Med. 2010 May-Jun;5(5):261-7. doi: 10.1002/jhm.628.

PMID:
20533570
12.

Antibiotic therapy and treatment failure in patients hospitalized for acute exacerbations of chronic obstructive pulmonary disease.

Rothberg MB, Pekow PS, Lahti M, Brody O, Skiest DJ, Lindenauer PK.

JAMA. 2010 May 26;303(20):2035-42. doi: 10.1001/jama.2010.672.

PMID:
20501925
13.

Neurocognitive effects of treatment interruption in stable HIV-positive patients in an observational cohort.

Robertson KR, Su Z, Margolis DM, Krambrink A, Havlir DV, Evans S, Skiest DJ; A5170 Study Team.

Neurology. 2010 Apr 20;74(16):1260-6. doi: 10.1212/WNL.0b013e3181d9ed09. Epub 2010 Mar 17.

14.

Use of HIV resistance testing after prolonged treatment interruption.

Iarikov DE, Irizarry-Acosta M, Martorell C, Rauch CA, Hoffman RP, Skiest DJ.

J Acquir Immune Defic Syndr. 2010 Mar;53(3):333-7. doi: 10.1097/QAI.0b013e3181c79ab0.

PMID:
20009764
15.

Improved measures of quality of life, lipid profile, and lipoatrophy after treatment interruption in HIV-infected patients with immune preservation: results of ACTG 5170.

Skiest DJ, Krambrink A, Su Z, Robertson KR, Margolis DM; A5170 Study Team.

J Acquir Immune Defic Syndr. 2008 Dec 1;49(4):377-83. doi: 10.1097/QAI.0b013e31818cde21.

16.

CD4+ T-cell decline after the interruption of antiretroviral therapy in ACTG A5170 is predicted by differential expression of genes in the ras signaling pathway.

Vahey MT, Wang Z, Su Z, Nau ME, Krambrink A, Skiest DJ, Margolis DM.

AIDS Res Hum Retroviruses. 2008 Aug;24(8):1047-66. doi: 10.1089/aid.2008.0059.

17.

Prevalence of and risk factors for methicillin-resistant Staphylococcus aureus (MRSA) nasal colonization in HIV-infected ambulatory patients.

Cenizal MJ, Hardy RD, Anderson M, Katz K, Skiest DJ.

J Acquir Immune Defic Syndr. 2008 Aug 15;48(5):567-71. doi: 10.1097/QAI.0b013e31817e9b79.

PMID:
18645516
18.

Choriocarcinoma in an AIDS patient--relapsing but not fatal.

Shah AM, Tidswell M, Prefontaine M, Skiest DJ, Pantanowitz L.

Int J STD AIDS. 2008 Jul;19(7):496-8. doi: 10.1258/ijsa.2007.007133.

PMID:
18574129
19.

Randomized study of dual versus single ritonavir-enhanced protease inhibitors for protease inhibitor-experienced patients with HIV.

Collier AC, Tierney C, Downey GF, Eshleman SH, Kashuba A, Klingman K, Vergis EN, Pakes GE, Rooney JF, Rinehart A, Mellors JW; AIDS Clinical Trials Group Protocol A5143 Team.

HIV Clin Trials. 2008 Mar-Apr;9(2):91-102. doi: 10.1310/hct0902-91.

PMID:
18474494
20.

High recurrence rate of CA-MRSA skin and soft tissue infections.

Skiest DJ, Cooper TW.

Arch Intern Med. 2007 Dec 10;167(22):2527author reply 2527. No abstract available.

PMID:
18071179

Supplemental Content

Loading ...
Support Center